Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May 26;2(5):e164.
doi: 10.1038/cddis.2011.48.

Reciprocal influence of the p53 and the hypoxic pathways

Affiliations
Review

Reciprocal influence of the p53 and the hypoxic pathways

A Sermeus et al. Cell Death Dis. .

Abstract

When cells sense a decrease in oxygen availability (hypoxia), they develop adaptive responses in order to sustain this condition and survive. If hypoxia lasts too long or is too severe, the cells eventually die. Hypoxia is also known to modulate the p53 pathway, in a manner dependent or not of HIF-1 (hypoxia-inducible factor-1), the main transcription factor activated by hypoxia. The p53 protein is a transcription factor, which is rapidly stabilised by cellular stresses and which has a major role in the cell responses to these stresses. The aim of this review is to compile what has been reported until now about the interconnection between these two important pathways. Indeed, according to the cell line, the severity and the duration of hypoxia, oxygen deficiency influences very differently p53 protein level and activity. Conversely, p53 is also described to affect HIF-1α stability, one of the two subunits of HIF-1, and HIF-1 activity. The direct and indirect interactions between HIF-1α and p53 are described as well as the involvement in this complex network of their respective ubiquitin ligases von Hippel Lindau protein and murine double minute 2. Finally, the synergistic or antagonistic effects of p53 and HIF-1 on some important cellular pathways are discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of the different pathways that have been proposed to explain the hypoxia-induced increase in p53 mRNA abundance, translation, p53 protein stability and activity as well as the hypoxia-induced decrease in p53 proteasomal degradation. ATM, ataxia-telangiectasia mutated; ATR, ataxia-telangiectasia mutated and Rad3-related; CHIP, carboxyl terminus of HSP70-interacting protein; HIF-1α, hypoxia-inducible factor-1α; MDM2, murine double minute 2; PNUTS, protein phosphatase-1 nuclear targeting subunit; PP1, protein phosphatase-1; pVHL, von Hippel Lindau protein; ROS, reactive oxygen species; Ub, ubiquitin
Figure 2
Figure 2
Schematic representation of the different pathways that have been proposed to explain the hypoxia-induced decrease in p53 gene transcription, p53 protein stability and activity as well as the hypoxia-induced increase in p53 protein degradation. CK2, casein kinase 2; HIF-1α, hypoxia-inducible factor-1α; HIPK2, homeodomain-interacting protein kinase 2; MDM2, murine double minute 2; NPM, nucleophosmin; ROS, reactive oxygen species; SIAH, seven in absentia homolog; Ub, ubiquitin; WSB-1, WD40-repeat/SOCS box protein
Figure 3
Figure 3
Schematic representation of the reciprocal modulation of HIF-1α, p53, pVHL and MDM2
Figure 4
Figure 4
Model for the regulation of p53 and HIF-1α protein level as well as of p53 and HIF-1 activity depending on the severity and the duration of hypoxia

References

    1. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–732. - PubMed
    1. Soussi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 2001;1:233–240. - PubMed
    1. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008;9:402–412. - PubMed
    1. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature. 2009;458:1127–1130. - PMC - PubMed
    1. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–299. - PubMed

Substances